지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.6
- 수록면
- 59 - 69 (11page)
- DOI
- 10.3831/KPI.2024.27.2.59
이용수
초록· 키워드
오류제보하기
This study investigates the therapeutic potential of Indigo Naturalis (IN) in treating a Inflammatory Bowel Disease (IBD). The objective is to comprehensively examine the effects and pharmacological mechanisms of IN on IBD, assessing its potential as an novel treatment for IBD. Analysis of 11 selected papers is conducted to understand the effects of IN, focusing on compounds like indirubin, isatin, indigo, and tryptanthrin. This study evaluates their impact on Disease Activity Index (DAI) score, colon length, mucosal damage, and macrophage infiltration in Dextran Sulfate Sodium (DSS)-induced colitis mice. Additionally, It investigate into the anti-inflammatory mechanisms, including Aryl hydrocarbon Receptor (AhR) pathway activation, Nuclear Factor kappa B (NF-κB)/nod-like receptor family pyrin domain containing 3 (NLRP3)/Interleukin 1 beta (IL-1β) inhibition, and modulation of Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MYD88)/NF-κB and Mitogen Activated Protein Kinase (MAPK) pathways. Immunomodulatory effects on T helper 17 (Th17)/regulatory T cell (Treg cell) balance and Glycogen synthase kinase-3 beta (GSK3-β) expression are also explored. Furthermore, the study addresses the role of IN in restoring intestinal microbiota diversity, reducing pathogenic bacteria, and increasing beneficial bacteria. The findings reveal that IN, particularly indirubin and indigo, demonstrates significant improvements in DAI score, colon length, mucosal damage, and macrophage infiltration in DSS-induced colitis mice. The anti-inflammatory effects are attributed to the activation of the AhR pathway, inhibition of inflammatory pathways, and modulation of immune responses. These results exhibit the potential of IN in IBD treatment. Notably, the restoration of intestinal microbiota diversity and balance further supports its efficacy. IN emerges as a promising and effective treatment for IBD, demonstrating anti-inflammatory effects and positive outcomes in preclinical studies. However, potential side effects necessitate further investigation for safe therapeutic development. The study underscores the need for future research to explore a broader range of active ingredients in IN to enhance therapeutic efficacy and safety.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn’s disease
Intestinal research
2019 .01
-
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
Intestinal research
2021 .01
-
Gossypetin supressed DSS-induced colitis through p38 signaling pathway
한국실험동물학회 학술발표대회 논문집
2021 .07
-
Immunomodulatory and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease (IBD): Turning Strong Rationale into Strong Evidence?
Journal of Pharmacopuncture
2018 .01
-
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Immune Network
2017 .02
-
장내 미생물과 염증장질환
대한의사협회지
2021 .09
-
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
Gut and Liver
2019 .01
-
Inflammatory bowel disease pathogenesis mediated by Th17 cells: cytokines, microbiota, and therapies
Journal of Biomedical and Translational Research
2024 .06
-
Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
대한류마티스학회지
2020 .01
-
Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
Gut and Liver
2017 .07
-
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Intestinal research
2024 .01
-
Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models
Intestinal research
2020 .01
-
Immunological pathogenesis of inflammatory bowel disease
Intestinal research
2018 .01
-
Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
Gut and Liver
2020 .01
-
Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel
Gut and Liver
2016 .01
-
우리나라 염증장질환의 현황
대한의사협회지
2021 .09
-
Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines
Journal of Ginseng Research
2023 .09
-
Microbial Modulation in Inflammatory Bowel Diseases
Immune Network
2022 .12
-
One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
Intestinal research
2022 .04
-
Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier
Immune Network
2022 .12
최근 본 자료
댓글(0)
0